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Abstract: Current anti-gastric ulcer agents have side effects, despite the progression and 
expansion of advances in treatment. This study aimed to investigate the gastroprotective 
mechanisms of Pithecellobium jiringa ethanol extract against ethanol-induced gastric 
mucosal ulcers in rats. For this purpose, Sprague Dawley rats were randomly divided into 
five groups: Group 1 (normal control) rats were orally administered with vehicle 
(carboxymethyl cellulose), Group 2 (ulcer control) rats were also orally administered  
with vehicle. Group 3 (positive control) rats were orally administered with 20 mg/kg 
omeprazole, Groups 4 and 5 (experimental groups) received ethanol extract of 
Pithecellobium jiringa ethanol extract at a concentration of 250 and 500 mg/kg, 
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respectively. Sixty minutes later, vehicle was given orally to the normal control group, and 
absolute ethanol was given orally to the ulcer control, positive control and experimental 
groups to generate gastric mucosal injury. The rats were sacrificed an hour later. The effect 
of oral administration of plant extract on ethanol-induced gastric mucosal injury was 
studied grossly and histology. The level of lipid peroxidation, (malondialdehyde—MDA), 
superoxide dismutase (SOD) and gastric wall mucus were measured from gastric mucosal 
homogenate. The ulcer control group exhibited severe gastric mucosal injury, and this 
finding was also confirmed by histology of gastric mucosa which showed severe damage  
to the gastric mucosa with edema and leucocyte infiltration of the submucosal layer.  
Pre-treatment with plant extract significantly reduced the formation of ethanol-induced 
gastric lesions, and gastric wall mucus was significantly preserved. The study also 
indicated a significant increase in SOD activity in gastric mucosal homogenate, whereas a 
significant decrease in MDA was observed. Acute toxicity tests did not show any signs of 
toxicity and mortality up to 5 g/kg. The ulcer protective effect of this plant may possibly be 
due to its preservation of gastric wall mucus along with increased SOD activity  
and reduction of oxidative stress (MDA). The extract is non-toxic, even at relatively  
high concentrations. 
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1. Introduction 
Pithecellobium jiringa (djengkol bean) is one of the members of the Leguminosae family. Its other 
scientific name is Archidendron jiringa. This plant originated from Southeast Asia, where it is known 
as jering in Malaysia, djengkol in Indonesian, krakos in Cambodia, and niang-yai in Thailand. In those 
countries, P. jiringa beans are typically consumed as a side dish with rice. Other people like to 
consume the beans with ground coconut [1]. Today P. jiringa is used in the production of organic 
pesticides. It contains djenkolic acid and sulphur which are able to inhibit and kill pests [2]. 
Significantly, the methanolic extract of P. jiringa was found to inhibit the activation of Epstein-Barr 
virus (EBV) by 30% or more. These findings highlight the potential of P. jiringa in inhibiting and 
targeting cancer cells [3]. In addition to containing proteins, dietary fibers and unsaturated fatty acids, 
it has been shown that P. jiringa contains protease inhibitors. As such, some of the inhibitory effects 
reported are for example the trypsin inhibitory activity which was found to be higher than the same 
activity described for soybeans [4]. This plant also found to contain high levels of polyphenolic 
compounds and has a potent antioxidant activity [5]. The present study was undertaken to investigate 
the gastroprotective mechanisms of P. jiringa ethanol extract against ethanol-induced gastric mucosal 
injury in experimental rats. 
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2. Results and Discussion 
2.1. Acute Toxicity Study 
In the acute toxicity study animals were treated with the P. jiringa extract at a dose of 0.5 g/kg and 
2 g/kg and kept under observation for 14 days. All the animals remained alive and did not manifest any 
significant visible of toxicity at these doses. Thus, clinical observations, serum biochemistry, and 
histopathology data did not show any significant differences between control and treated groups 
(Figure 1, Tables 1 and 2). We conclude that P. jiringa extract orally administered to rats was safe and 
that no drug-related toxicity was detected, even at the highest dose investigated. 
Figure 1. Histological sections of liver and kidney after the acute toxicity test. Rats (1a and 
1b) treated with vehicle (CMC). Rats (1c and 1d) treated with 0.5 g/kg P. jiringa extract. 
Rats (1e and 1f) treated with 2 g/kg P. jiringa extract. There is no significant differences in 
structures of liver and kidney between treated and control groups (H & E stain 20×). 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
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Table 1. Renal function test of rats in acute toxicity study of P. jiringa extract. 
Dose  
(5 mL/kg) 
Sodium 
(mmol/L) 
Pottasium 
(mmol/L) 
Chloride 
(mmol/L) 
CO2 
(mmol/L) 
Anion gap 
(mmol/L) 
Urea 
(mmol/L) 
Creatinine 
(µmol/L) 
Vehicle (CMC) 137.25 ± 0.41 5.03 ± 0.17 102.03 ± 0.15 23.03 ± 0.82 18.16 ± 0.72 5.63 ± 0.41 50.18 ± 1.34 
LD (0.5 g/kg) 137.11 ± 0.42 5.21 ± 0.15 103.61 ± 1.22 21.74 ± 0.17 17.07 ± 1.35 4.96 ± 0.43 48.97 ± 0.81 
HD (2 g/kg) 137.21 ± 0.50 5.12 ± 0.14 103.07 ± 0.76 22.8 ± 0.86 17.73 ± 0.51 5.93 ± 0.39 48.60 ± 1.80 
Values expressed as mean ± S.E.M. There are no significant differences between groups. Significant value at p < 0.05. 
Table 2. Liver function test of rats in acute toxicity study of P. jiringa extract. 
Dose  
(5 mL/kg) 
Total protein 
(g/L) 
Albumin 
(g/L) 
Globulin 
(g/L) 
TB 
(µmol/L) 
CB 
(µmol/L) 
AP 
(IU/L) 
ALT 
(IU/L) 
AST 
(IU/L) 
GGT 
(IU/L) 
Vehicle (CMC) 72.33 ± 1.44 11.39 ± 0.51 59.09 ± 1.37 1.96 ± 0.19 0.96 ± 0.16 134.78 ± 9.51 53.05 ± 3.24 154.61 ± 9.37 4.96 ± 0.93 
LD (0.5 g/kg) 71.41 ± 0.52 11.65 ± 0.33 59.45 ± 0.38 2.12 ± 0.15 1.00 ± 0.00 133.37 ± 8.66 51.90 ± 1.37 156.07 ± 3.66 5.03 ± 1.28 
HD (2 g/kg) 71.84 ± 1.03 11.62 ± 0.14 60.11 ± 0.68 1.84 ± 0.24 1.00 ± 0.00 134.13 ± 6.55 52.21 ± 3.22 155.02 ± 5.38 5.38 ± 1.09 
Values expressed as mean ± S.E.M. There are no significant differences between groups. p < 0.05 were considered statistically significant.  
TB: Total bilirubin; CB: Conjugated bilirubin; AP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase;  
GGT: G-Glutamyl Transferase. 
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2.2. Gross Appearance of Gastric Lesions 
Rats pretreated with omeprazole (GIII), or with both doses of ethanol extract (GIV and GV) before 
being given absolute alcohol showed significantly reduced areas of gastric ulcer formation compared 
to GII (Figure 2, Table 3). Flattening of gastric mucosal folds was also observed in GIV and GV rats. 
Moreover, the mucosal damage was significantly reduced in size and severity in GIII, GIV and GV. 
On the other hand, GII animals showed sever ulcer formation (Figure 2, Table 3). 
Figure 2. Gross appearance of the gastric mucosa in rats. (a) Rats pre-treated with CMC 
(normal control). No disturbance of gastric mucosa. (b) Rats pre-treated with CMC (ulcer 
control). Severe injuries are seen in the gastric mucosa. Absolute ethanol produced extensive 
visible hemorrhagic necrosis of gastric mucosa. (c) Rats pre-treated with of omeprazole  
(20 mg/kg). Injuries to the gastric mucosa are much milder compared to the injuries seen in 
the ulcer control rats. (d) Rats pre-treated with P. jiringa (250 mg/kg). Moderate injuries to 
the gastric mucosa are seen. (e) Rat pre-treated with P. jiringa (500 mg/kg). Mild injuries are 
seen in the gastric mucosa; and flattening of the gastric mucosa is seen. 
   
(a)                                                   (b)                                                   (c) 
 
(d)                                                     (e) 
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Table 3. Effect of P. jiringa on ethanol-induced changes in gastric wall mucus, Superoxide dismutase, Lipid peroxidation and ulcers area  
in rats. 
Group Pre-treatment 
(5 mL/kg) 
Post-treatment 
(5 mL/kg) 
Gastric wall mucus  
(µg Alcian blue/g wet stomach) 
SOD (mU of 
SOD/mg tissue) 
MDA (μmol of 
MDA/mg tissue) 
ulcers area (mm2) 
Mean ± SEM 
Inhibition 
(%) 
GI CMC CMC 930.50 + 27.44 a 165.35 ± 7.68 a 30.24 ± 4.09 a - - 
GII  CMC Absolute ethanol 562.21 + 21.33 b 75.15 ± 4.29 b 91.67 ± 6.12 b 836.67 ± 2.06 a - 
GIII 20 mg/kg 
Omeprazole 
Absolute ethanol 815.07 + 25.17 c 135.18 ± 5.94 a 44.06 ± 4.88 c 68.33 ± 2.05 b 92.01 
GIV 250 mg/kg 
P. jiringa 
Absolute ethanol 795.67 + 19.98 c 152.33 ± 5.79 a 47.17 ± 3.97 c 228.17 ± 1.51c 72.17 
GV 500 mg/kg 
P. jiringa 
Absolute ethanol 857.26 + 26.03 c 162.06 ± 6.17 a 40.08 ± 4.36 c 156.33 ± 1.84 d 80.55 
All values are expressed as mean ± standard error mean. Means with different superscripts are significantly different. The mean difference is significant at 
the p < 0.05 level. 
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2.3. Histological Changes of Gastric Mucosa 
Microscopic observations of ethanol-induced gastric lesions in ulcers control rats (GII) illustrated 
significant and extensive damage in the gastric mucosa with oedema and inflammatory cells 
infiltration in the submucosal layer (Figure 3). Rats in GIV and GV and those treated with omeprazole 
(GIII), displayed better protection of their gastric mucosa as seen by the reduction of the ulcerated 
areas (Figure 3). Reduced submucosal oedema and the inflammatory reactions were also observed in 
these groups. The histological appearance in GIV was somewhat similar to GIII (Figure 3). 
Figure 3. Histological study of the absolute ethanol-induced gastric mucosal damage in 
rats. (a) Rats pre-treated with CMC (normal control). No disturbance of gastric mucosa.  
(b) Rats pre-treated with CMC (ulcer control). There is severe disruption to the surface 
epithelium and necrotic lesions penetrate deeply into mucosa (orange arrow) and extensive 
edema of submucosal layer and leucocytes infiltration are present (white arrow). (c) Rats 
pre-treated with omeprazole (20 mg/kg). Very mild disruption of the surface epithelium 
mucosa is present, but deep mucosal damage is absent. (d) Rats pre-treated with P. jiringa 
(250 mg/kg). There is moderate disruption to the surface epithelium (orange arrow) with 
edema and leucocyte infiltration of the submucosal layer (white arrow). (e) Rat pre-treated 
with P. jiringa (500 mg/kg). Mild disruptions of surface epithelium are present but deep 
mucosal damage is absent (orange arrow). There is slight edema with leucocyte infiltration 
of the submucosal layer (white arrow) (H&E stain 10×). 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
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Figure 3. Cont. 
 
(e) 
2.4. Effect of P. jiringa on Ethanol-Induced Changes in the Gastric Wall Mucus 
The treatment of rats with ethanol significantly decreased the Alcian blue binding capacity of the 
gastric wall mucus in the ulcer control animals. Pre-treatment with P. jiringa extract at doses of  
250 and 500 mg/kg significantly enhanced the Alcian blue binding capacity of the gastric mucosa and 
increased the amount of gastric mucus in ethanol-ulcerated rats (Table 3). 
2.5. Effect of P. jiringa on Ethanol-Induced Changes in Gastric Antioxidant Enzyme (SOD) 
Ethanol reduced the SOD activity in ulcer control stomachs pretreated with vehicle when compared 
with normal group. Pre-treatment with plant extract increased the activity of the enzyme compared 
with the ulcer control group. Similarly, omeprazole increased SOD activity compared with the ulcer 
control group (Table 3). 
2.6. Measurement of Membrane Lipid Peroxidation (μmol MDA/mg of Tissue) 
Lipoperoxidation in the ulcer control stomachs was significantly higher when compared with the 
normal control group. In the stomachs of the animals pretreated with P. jiringa or omeprazole a 
decrease in lipoperoxidation was observed compared with the ulcer control stomach (Table 3). The 
acute toxicity test did not show any signs of toxicity or mortality when administered orally up to  
2 g/kg. Peptic ulcers are caused by an imbalance between the protective and aggressive mechanisms of 
the mucosa and are the result of the association of several endogenous factors and aggressive 
exogenous factors that are related to living conditions [6]. Ethanol produces necrotic lesions by direct 
necrotizing action, which in turn reduces defensive factors, including the secretion of bicarbonate  
and production of mucus [7]. The gastric wall mucus is thought to play an important role as a 
defensive barrier against gastrointestinal damage [8]. Pre-treated with the P. jiringa extract 
significantly increased the gastric mucus content in rats with ethanol-induced ulcers suggests that the 
gastroprotective effect of this plant is mediated partly by preservation of the gastric wall mucus. 
Gastric wall mucus depletion induced by ethanol is also one of the pathogenic mechanisms responsible 
for gastric lesions [9]. It has been reported that certain anti-ulcer drugs increase the amount of gastric 
mucus secretion in the gastric mucosa [10]. The increase in bound Alcian blue indicates the protective 
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effect of orally administered P. jiringa, which may occur through the formation of protective 
complexes between this plant extract and the mucus that acts as a barrier against necrotizing agents 
introduced in the stomach [11]. The preservation of adherent mucus on the glandular mucosa is one of 
the contributing factors in the prevention of gastric mucosal damage induced by chemical irritants [12].  
The oral administration of absolute ethanol to rats produces linear hemorrhagic lesions, extensive 
submucosal edema, inflammatory cell infiltration, and epithelial cell loss in the stomach, which are the 
typical characteristics of alcohol injury [13]. The pathogenesis of ethanol-induced gastric mucosal 
damage occurs directly and indirectly through various mediators, such as lipoxygenase, cytokines, and 
oxygen-derived free radicals [14]. Mucus secretion is regarded as a crucial defensive factor in the 
protection of the gastric mucosa from gastric lesions [15]. The results of the present study showed that 
P. jiringa extract has an effective anti-ulcer activity against ethanol-induced gastric mucosal injury. 
The plant extract increased the mucus of the gastric wall, which is consistent with results reported by 
Thirunavukkarasu et al. [16]. Omeprazole, a proton pump inhibitor (PPI), exhibits an anti-secretory 
and protective effect [17]. Omeprazole is effective in treating peptic ulcer disease and gastroesophageal 
reflux in short- and long-term use [18]. The pathogenesis of mucosal damage in the stomach includes the 
generation of reactive oxygen species (ROS) that appear to play a vital role in the formation of lipid 
peroxides and is accompanied by the impairment of the activity of antioxidant enzymes in cells [19]. 
Oxidative stress plays an important role in the pathogenesis of various diseases, including gastric 
ulcer disease, with antioxidants reported to play a significant role in the protection of the gastric 
mucosa against various necrotic agents [20]. Antioxidants could help protect the cells from damage 
caused by oxidative stress and enhance the body’s defense systems against degenerative diseases. The 
administration of antioxidants inhibits ethanol-induced gastric injury in rats [21]. P. jiringa extract has 
been shown to contain antioxidants [5], and it is likely that the gastroprotective effect exerted by this 
plant extract could be attributed to its antioxidant properties. Our results revealed the protection of the 
gastric mucosa and inhibition of leukocyte infiltration to the gastric wall in rats pretreated with  
P. jiringa extract. The activation and infiltration of neutrophils appear to be involved in the initial 
processes that form the lesions. Similarly, Abdulla et al. [22] demonstrated that the reduction of 
neutrophil infiltration into ulcerated gastric tissues promoted the prevention of gastric ulcers in rats. 
Wasman et al. [23] showed that the oral administration of plant extract before ethanol administration 
significantly decreased neutrophil infiltration into the gastric mucosa. Neutrophils mediate lipid 
peroxidation through the production of superoxide anions [24]. Neutrophils are a major source of 
inflammatory mediators and can release potent reactive oxygen species, such as superoxide, hydrogen 
peroxide and myeloperoxidase-derived oxidants. These reactive oxygen species are highly cytotoxic 
and can induce tissue damage [25]. We observed a flattening of the mucosal folds, which suggests that 
the gastroprotective effect of the P. jiringa leaf extract might be due to a decrease in gastric motility. It 
has been reported that changes in gastric motility may play a role in the development and prevention of 
experimental gastric lesions [22]. The relaxation of the circular muscles may protect the gastric 
mucosa through the flattening of the folds. This flattening will increase the mucosal area exposed to 
necrotizing agents and reduce the volume of the gastric irritants on the rugal crest [22,23]. 
MDA is the final product of lipid peroxidation and is used to determine lipid peroxidation  
levels [26]. Gastric MDA was increased in the ulcer control group and decreased by P. jiringa extract 
administration, another indicator of the potential antioxidant functionality of this plant. Lipid 
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peroxidation causes a loss in membrane fluidity, impaired ion transport, membrane integrity, and 
finally, the loss of cellular functions. 
The gastric tissue homogenate from animals pre-treatment with omeprazole or plant extract showed 
significant decrease in the levels of MDA and elevation of the levels of SOD in response to absolute 
ethanol. Free radicals and reactive oxygen species (ROS) are continuously produced in the human 
body. These oxygen species are a cause of cellular damage. SOD converts superoxide to hydrogen 
peroxide, which is transformed into water by catalase in lysosomes or by glutathione peroxidase in  
the mitochondria [27]. 
SOD, which plays an important role in protecting gastrointestinal mucosa, owes its antioxidant 
properties to its ability to scavenge superoxide anions. The increase in SOD level in the experimental 
groups of the present study clearly point to an antioxidant mechanism underlying its gastroprotective 
action, while the ability of the plant extract to prevent lipid peroxidation in vitro reinforces its potential 
use as a therapeutic drug for free radical pathologies. Our results revealed that the activity of SOD was 
reduced in gastric tissue homogenates from the ulcer control group. The decrease in the activity of 
SOD in tissue homogenate may be due to the increased production of reactive oxygen radicals, which 
can reduce the activity of this enzyme [28]. The reduction of SOD enzyme in gastric homogenate may 
lead to a number of deleterious effects. Lipid peroxidation has been observed to be an important 
pathophysiological event in a variety of diseases, including gastric ulcer disease [29]. Lipinski [30] 
showed that reactive oxygen species can induce cellular events such as enzyme inactivation, DNA 
strand cleavage and membrane lipid peroxidation. Oxidative stress is associated with the peroxidation 
of cellular lipids [28]. In the ulcer control rats, the MDA levels were observed to be higher than the 
normal control rats, indicating lipid peroxidation. The levels of MDA in the gastric tissue of rats that 
received P. jiringa were significantly decreased when compared to the ulcer control rats. This result 
suggests that the plant extract could improve the pathological condition of gastric ulcer disease by a 
reduction of lipid peroxidation. 
3. Experimental 
3.1. Drugs and Chemicals 
In this study, Omeprazole was used as the reference anti-ulcer drug, and was obtained from  
the University Malaya Medical Centre (UMMC) Pharmacy. The drug was dissolved in 0.5% 
carboxymethylcellulose and given orally to six rats (GII) in concentrations of 20 mg/kg 5 mL/kg) 
according to the recommendations of Mahmood et al. [31]. 
3.2. Preparation of Carboxymethylcellulose (Vehicle) 
0.5% carboxymethylcellulose (CMC) was prepared by adding 0.5 g of absolute carboxylmethyl 
cellulose to 100 mL of distilled water. 
3.3. Preparation of the Ethanol Extraction 
The plant was peeled and beans were ground. Ground beans (100 g) were weighed and mixed with 
95% ethanol (1,000 mL) (i.e., 1:10 ratio) [31]. Then, the mixture was placed in a conical flask which 
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was then covered with aluminum foil. The mixture was kept at room temperature 7 days for 
maceration. Next, the extract was filtered and concentrated using an EYELA rotator evaporator. Once 
evaporation was concluded, the extract was collected in a universal bottle and kept in incubator at  
45 °C overnight. The dry extract was then dissolved in CMC and administered orally to rats in 
concentrations of 250 and 500 mg/kg body weight (5 mL/kg body weight) according to the 
recommendation of Wasman et al. [23]. 
3.4. Acute Toxicity Test and Experimental Animals 
Adult healthy male and female Sprague-Dawley rats (6–8 weeks old) were obtained from the 
Animal House, Faculty of Medicine, University of Malaya, Kuala Lumpur (Ethic Permit No. 
PM/27/07/2010/MAA (R). The rats weighed between 150–180 g. The animals were given standard rat 
pellets and tap water. The acute toxicity study was used to determine a safe dose for the extract. Thirty 
six Sprague Dawley rats (18 males and 18 females) were assigned equally each into three groups 
labeled as vehicle (CMC); 0.5 g/kg and 2 g/kg of P. jiringa extract preparation, respectively. The 
animals were fasted overnight (food but not water) prior to dosing. Food was withheld for a further  
3 to 4 h after dosing. The animals were observed for 30 min and 2, 4, 8, 24 and 48 h after the 
administration for the onset of clinical or toxicological symptoms. Mortality, if any was observed over 
a period of 2 weeks. The animals were sacrificed on the 15th day. Histology, hematological and serum 
biochemical parameters were determined following standard methods [23,31]. The study was 
appproved by the Ethics Committee for Animal Experimentation, Faculty of Medicine, University of 
Malaya, Malaysia. Throughout the experiments, all animals received human care according to the 
criteria outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National 
Academy of Sciences and published by the National Institutes of Health. 
3.5. Experimental Animals for Gastric Ulcer 
Adult male Sprague-Dawley rats (200–250 g) were provided by the Animal House, Faculty of 
Medicine, University of Malaya (Ethics Permit No. PM/27/07/2010/MAA (R). All animals used for 
the study had ethical clearance from the Animal User’s Committee of the Faculty of Medicine, 
University of Malaya. The rats were deprived of food for 24 h before the experiment and only allowed 
access to water 2 h prior to the experiment. They were randomly divided into five groups, six rats per 
group, and individually housed in cages with a wide-mesh wire bottom to prevent coprophagy and 
dominancy. Throughout the experiment, all animals received human care according to the criteria 
outlined in the “Guide for the Care and Use of Laboratory Animals”. 
3.6. Treatment 
Gastric ulcers were induced by orogastric intubation of absolute ethanol (5 mL/kg) according  
to the method described by Abdulla et al. [22] (Table 3). The rats were euthanized 60 minutes later 
(under an overdose of xylazin and ketamine anesthesia) and their stomachs were immediately excised 
(Wasman et al. [23]). 
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3.7. Gross Gastric Lesions Evaluation 
Ulcers of the gastric mucosa appear as elongated bands of hemorrhagic lesions parallel to the long 
axis of the stomach. Gastric mucosa of each rat was thus examined for damage. The length and width 
of the ulcer (mm) were measured by a planimeter (10 × 10 mm2 = ulcer area) under dissecting 
microscope (1.8 ×). The ulcerated area was measured by counting the number of small squares,  
2 mm × 2 mm, covering the length and width of each ulcer band. The sum of the areas of all lesions for 
each stomach was applied in the calculation of the ulcer area (UA) where in the sum of small  
squares × 4 × 1.8 = UA (mm2) according to the recommendation of Mahmood et al. [31]. The 
inhibition percentage (I.0%) was calculated by the following formula according to the recommendation 
of Wasman et al. [23]: 
(I%) = [(UAcontrol − UAtreated)  UAcontrol] × 100% 
3.8. Determination of Gastric Wall Mucus 
Gastric wall mucus was determined according to the modified procedure of Corne et al. [32]. The 
glandular segment of the stomach was separated from the lumen of the stomachs, weighed and 
transferred immediately to 10 mL of 0.1% w/v Alcian blue solution (in 0.16 mol sucrose solution 
buffered with 0.5 mL sodium acetate at pH 5). Tissue was stained for 2 h in Alcian blue and excess 
dye was removed by two successive rinses with 10 mL of 0.25 M sucrose. Dye complexed with the 
gastric wall mucus was extracted with 10 mL of 0.5 mol magnesium chloride, which was intermittently 
shaken for 1 min at 30 min intervals for 2 h. Four milliliters of blue extract were then vigorously 
shaken with an equal volume of diethyl ether. The resulting emulsion was centrifuged at 3,000 g for  
10 min and the absorbance of the aqueous layer was recorded at 580 nm. The quantity of Alcian blue 
extracted per gram of wet glandular tissue was then calculated. 
3.9. Microscopic Studies 
The opened stomachs were preserved in 10% buffered formalin overnight after cutting them into 
small pieces. The tissues were processed by automated tissue processing the next day. Next, the biopsies 
were embedded in paraffin wax and sectioned at 5 µm thickness by microtome and then stained with 
haematoxylin and esin (H & E) [22,33]. The tissue sections were assessed for histopathological changes 
such as congestion, edema, hemorrhage and necrosis using a light microscope. 
3.10. Estimation of SOD Antioxidant Enzyme and Proteins Concentration 
Superoxide dismutase (SOD) activity was determined according to the method described by 
Marklund and Marklund [34]. The reaction mixture consisted of 0.5 mL of Tris-buffer (50 mM;  
pH-8.2), 0.5 mL pyragallol (0.5 mmol), 0.5 mL EDTA (1 mmol), and in different volumes, 0.025 mL, 
0.05 mL, 0.075 mL, and 0.1 mL of tissue homogenate. The change in absorbance was recorded at  
420 nm. Activity was reported by its ability to inhibit 50% reduction of pyragallol and the result is 
expressed as mU/min/mg protein. 
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3.11. Measurement of the Membrane Lipids Peroxidation 
The rate of lipoperoxidation in the gastric mucous membrane was estimated by determination  
of malondialdehyde (MDA) using the Thiobarbituric Acid Reactive Substances (TBARS) test. The 
stomachs were washed with saline to minimize the interference of hemoglobin with free radicals and to 
remove blood adhered to the mucous membrane. The stomachs were homogenized to 10% of tissue 
with potassium phosphate buffer. Then, 250 μL was removed and stored at 37 °C for 1 h, after which 
400 μL of 35% perchloric acid was added, and the mixture was centrifuged at 14,000 rpm for 20 min 
at 4 °C. The supernatant was removed, mixed with 400 μL of 0.6% thiobarbituric acid and incubated at 
95–100 °C for 1 h. After cooling, the absorbance at 532 nm was measured. A standard curve was 
generated using 1,1,3,3-tetrametoxypropane. The results were expressed as nmol of MDA/mg of 
protein. The concentration of proteins was measured using the method described by Bradford [35]. 
Measurement of total protein in the stomach sample after ethanol-induced lesions. The method is based 
on the interaction of the Coomassie Blue G250 dye with proteins. At the pH of the reaction, the 
interaction between proteins of high molecular weight and the dye causes a shift in the dye to the 
anionic form, which absorbs strongly at 595 nm. Solutions of albumin standard, distilled water, buffer 
and samples were added to the wells. For sample preparation, 2 μL of sample and 38 μL of buffer were 
added to each well. Then, 200 μL Bradford’s solution (diluted 5×) was added to each well. After  
5 min, a reading was taken at the wavelength of 595 nm [35]. 
3.12. Statistical Analysis 
All values were reported as mean ± S.E.M. The statistical significance of differences between 
groups was assessed using one-way ANOVA. A value of p < 0.05 was considered significant. 
4. Conclusions 
We conclude that P. jiringa plays a protective role against gastric ulcers, and its anti-ulcer effect is 
related to an increase of adherent mucus, which may inhibit the generation of oxygen-derived free 
radicals. The gastroprotective effects of this plant in experimental ulcers induced by absolute ethanol 
could be related to its SOD activity and a decrease in lipid peroxidation. 
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